TachoSil vs DuraSeal for Supporting Dural Sealing in Adults
Official title: Effectiveness and Safety of TachoSil® Fibrin Sealant Patch in Comparison to a Hydrogel Sealant for Supporting Dural Sealing Among Adult Inpatients in the United States: A Retrospective, Non-Inferiority, Cohort Study
Run by Corza Medical GmbH · NCT07927413 · Data updated 2026-11-12
This retrospective study looks at whether TachoSil works as well as DuraSeal to prevent CSF leaks or pseudomeningoceles after cranial or spinal surgeries in adults.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 600 (estimated) |
| Sponsor | Corza Medical GmbH Industry-sponsored |
| Drugs / interventions | radiation |
| Locations | 6 sites (Baltimore, Maryland and 5 other locations) |
| Status | Recruiting |
| Started | February 13, 2026 |
| Main results expected | November 16, 2026 |
| Study ends | November 16, 2026 |
| Registry record updated | November 10, 2026 |
| Trial ID | NCT07927413 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) who had inpatient cranial or spinal surgery with dural sealing and used either TachoSil or DuraSeal at participating sites between 2017 and 2026.
✕Probably not a fit
Patients whose surgery did not involve dural sealing with these sealants or who do not experience CSF leaks or pseudomeningoceles may not see a benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study analyzes medical records from adults who had cranial or spinal surgery with dural sealing, comparing outcomes between TachoSil and DuraSeal sealants. It uses 1:1 propensity score matching to see if TachoSil is non-inferior to DuraSeal and to evaluate safety and effectiveness through 90-day post-surgery events. Primary outcomes include clinically evident CSF leak or pseudomeningocele within 90 days, with additional safety considerations being monitored. Data are drawn from multiple US institutions and led by Corza Medical GmbH, with CIAS, Premier, Inc. Applied Sciences as collaborators.
Why it matters
Potential benefit: If successful, the findings could inform surgeons' choice of dural sealants to reduce CSF-related complications and improve patient safety.
How similar studies have gone: Prior work in dural sealant comparisons has shown varying effectiveness; this study adds real-world evidence using propensity score matching.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged ≥ 18 years * Had an inpatient encounter to select sites with a cranial or spinal neurological surgery that involves dural sealing performed and discharged during January 1, 2017, and March 31, 2026 * Had use of TachoSil® or DuraSeal® sealants during the cranial or spinal neurological surgery as supportive dural sealing method Note: Any surgery meeting the above criteria is considered index surgery Exclusion Criteria: * Index surgery was trauma-related * Had an infection within 7 days prior to index date * Had any neurosurgery involving dural opening during the 12-month look-back period * Had neoplasm of dura mater/meningioma, requiring resection of dura during index visit (the earliest visit meeting selection criteria) or 12-month look-back period * Was pregnant at index visit * Had a CSF leak during the 12-month look-back period * If the surgical approach was transbasal or transpetrosal, if the arachnoid membrane and CSF- containing system remained intact, or if there was \>1 dura opening (excluding extra ventricular or lumbar drains) during index surgery * Had use of Evarrest patch, Tisseel, Adherus, CraniSeal, Duragen, fibrin glue or other dural sealing products during index surgery * Had radiation therapy to surgical field in the 3 months prior to index date * Had chronic corticosteroid use in the 3 months prior to index date * Had both TachoSil® and DuraSeal® used for dural closure during index neurological surgery
Where it's running
-
Johns Hopkins University
Baltimore, Maryland, United States Recruiting -
Columbia University
New York, New York, United States Recruiting -
University of Cincinnati College of Medicine
Cincinnati, Ohio, United States Recruiting -
Thomas Jefferson University
Philadelphia, Pennsylvania, United States Recruiting -
Alleghany Health Network
Pittsburgh, Pennsylvania, United States Recruiting -
Swedish Health Services
Seattle, Washington, United States Recruiting
Study contacts
- Principal investigator: Ning Rosenthal, MD, PhD, MPH, — Premier Inc
- Study coordinator: Jeff Wilson
- Email: Jeff.Wilson@corza.com
- Phone: 416-578-9058
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cerebrospinal fluid leak after brain tumor surgery
This project will look at adults having planned supratentorial craniotomy for intracranial tumors to see how often cerebrospinal fluid leaks occur and what complications they cause.
-
Sealant versus no sealant to prevent CSF leaks after endoscopic endonasal skull base surgery
We will try fibrin or synthetic sealants versus no sealant to see if they prevent postoperative CSF leaks in adults having endoscopic endonasal skull base surgery who are judged to be at low risk for leaks.
-
Registry for spontaneous intracranial hypotension and post-dural puncture headache
This study is collecting information from people with spinal fluid leaks to better understand the causes and symptoms of headaches related to spontaneous intracranial hypotension and post-dural puncture headache.
-
Dural Sealant Used After Neurosurgery to Help Ensure Watertight Closure
This registry follows adults who receive Immiseal after neurosurgical dural repair to see how safe and effective it is in real-world use.
-
Comparing two dural sealants for preventing cerebrospinal fluid leaks after brain surgery
This study is testing whether a new sealant called CraniSeal is as good as the existing DuraSeal at preventing leaks of spinal fluid after brain surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.